NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial
NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial
Read moreFri, 01st May 2020 16:17
NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial
Read moreGenedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year
Read more(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.
Read more(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV
Read moreLONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,
Read more(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.
Read moreLONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end
Read more(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.
Read moreLONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,
Read moreLONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus
Read more(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV diagnostics and therapy in a pharmacy setting when compared conventional treatment pathways.
Read moreLONDON (Alliance News) - Diagnostics company Genedrive PLC said Wednesday it appointed Chris Yates as non-executive director with immediate effect.Yates has been Chief Executive Officer of
Read moreLONDON (Alliance News) - Genedrive PLC said Wednesday it partnered with the Foundation for Innovation of New Diagnostics, or FIND, which will evaluate its hepatitis C virus kit.The kit is a
Read moreLONDON (Alliance News) - Genedrive PLC's said Wednesday it was awarded a multi-partner grant to develop a pharmacogenetic test to fight antibiotic-related hearing loss in newborn molecular was
Read moreLONDON (Alliance News) - Genedrive PLC said Monday it proposed the disposal of the its contract research and pharmacogenomics divisions for up to GBP1.9 million in cash to biotechnology company 2
Read more